~~<i id='463431C0AD'><strike id='463431C0AD'><tt id='463431C0AD'><pre id='463431C0AD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

Wikipedia

author：leisure time 2025-10-02 11:10:50 - browse：94726

The FDA building -- First Opinion coverage from STAT — Adobe

WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： GSK to buy asthma

leisure time

Wikipedia

focus

hotspot

entertainment

leisure time

Thedocumentary"ThreeIdenticalStrangers"chroniclestripletsborninthe1960swhowereseparatedasinfantsanda

WSS

Risky weight loss products often used by teens globally, per study

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Three issues to watch in global health in 2024

Caregivers of transplant patients call for more support, training

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Doulas covered by Medicaid under New York's new plan

hotspot

Wikipedia

leisure time

Medical leaders decry Supreme Court decision on affirmative action

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Medical records are filled with copy

Health tech startups drop sharply from 2021 highs

Walensky prepares to leave CDC — and Congress — behind

Address the ethical violations that led to 'Three Identical Strangers'

Medical leaders decry Supreme Court decision on affirmative action

Biotech reporter’s notebook: A sunnier mood at JPM 2024

In age of alternative facts, a scholarly course on calling out crap

How one patient went off dialysis — and others can too

Wikipedia

New England Journal of Medicine addresses racist history, slavery

Medicaid, Medicare dual

Idaho abortion case may prompt more restrictions in other states

Readout LOUD podcast: live from JPM 2024

Biogen shutters digital health group, ends Apple study, in cost cutting move

Designating disabled people as health disparity population is crucial

focus

hotspot

entertainment

leisure time